Protection against Shiga Toxins
Shiga toxins consist of an A-moiety and five B-moieties able to bind the neutral glycosphingolipid globotriaosylceramide (Gb3) on the cell surface. To intoxicate cells efficiently, the toxin A-moiety has to be cleaved by furin and transported retrogradely to the Golgi apparatus and to the endoplasmi...
Main Authors: | Simona Kavaliauskiene, Anne Berit Dyve Lingelem, Tore Skotland, Kirsten Sandvig |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/9/2/44 |
Similar Items
-
Shiga Toxin Therapeutics: Beyond Neutralization
by: Gregory Hall, et al.
Published: (2017-09-01) -
Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin
by: Joshua C. Bunger, et al.
Published: (2015-06-01) -
Prevalence and characteristics of Shiga-toxin producing Escherichia coli (STEC) isolated from beef slaughterhouse
by: Md. Shafiullah Parvej, et al.
Published: (2018-06-01) -
Farm animal contact is associated with progression to Hemolytic uremic syndrome in patients with Shiga toxin-producing Escherichia coli — Indiana, 2012–2018
by: Madhura S. Vachon, et al.
Published: (2020-12-01) -
Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing <i>Escherichia coli</i> (STEC) Strain B2F1 in Streptomycin (Str)-Treated Mice
by: Beth A. McNichol, et al.
Published: (2021-01-01)